Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REACH Côte d'Ivoire: Feasibility and Acceptability of Integrating Mass Distribution of Azithromycin to Children 1-11 Months Into a Trachoma Mass Drug Administration Campaign to Reduce Child Mortality

NCT04617626 is registered in ClinicalTrials.gov with FHI 360 as lead sponsor.

NCT NCT04617626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04617626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REACH Côte d'Ivoire: Feasibility and Acceptability of Integrating Mass Distribution of Azithromycin to Children 1-11 Months Into a Trachoma Mass Drug Administration Campaign to Reduce Child Mortality
Lead sponsor
FHI 360
Phase
Not applicable
Overall status
Completed
Start date
November 20, 2020
Completion date
January 31, 2021
Enrollment
1,735 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

azithromycin, child mortality